Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention
Details for the panel are as follows:
|Title:||“The Future of Influenza Vaccines”|
|Date and Time:||Wednesday, June 5, 11:00 a.m.|
|Moderator:||Bruce Gellin, M.D., M.P.H., President, Global Immunization, Sabin Vaccine Institute|
Luciana Borio, Vice President, Technical Staff, In-Q-Tel
Bruce D. Clark, Ph.D., Chief Executive Officer and President, Medicago, Inc.
Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research (CBER) at Food and Drug Administration
Gordon Naylor, President, Seqirus
Paul Radspinner, President and Chief Executive Officer, FluGen Inc.
Senior Manager, Investor & Public Relations
Source: Novavax, Inc.